Clinical Development of an Opioid Minimizing Combination Therapeutic
NCBiotech Grants & Loans
See the full listing of all NCBiotech grants and loans awarded since July 2012.
Amalgent Therapeutics (Greenville, NC) is seeking 505(b)(2) approval for a fixed-dose oral tablet combination of two FDA approved drugs, morphine and pramipexole, that enables reduction of morphine to a less addictive dose. The SRL funds will be used to perform animal studies and prepare for a pre-IND meeting.